Disease Progression Among Commercially Insured HDV Infected Patients in the US
Telemedicine Consult - Dr. Gish
Schedule Telemedicine Consult with Dr. Gish

Disease Progression Among Commercially Insured HDV Infected Patients in the US

Disease Progression Among Commercially Insured Hepatitis Delta Virus Infected Patients in the United States

  • HDV patients had a significantly higher rate of severe liver disease progression as compared to HBV monoinfected patients
  • HDV patients had a 54%, 60%, and 62% higher risk of progression from noncirrhotic disease to CC, DCC, and HCC, respectively, than HBV monoinfected patients

Download PowerPoint


Metadata